Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

NCT07549451 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Phase II
Imetelstat
Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases

Interventions

DRUG: Imetelstat

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]